Hikal - Quaterly Results

02 Feb 2023 Evaluate
A minor change in the total revenue was seen in the December 2022 quarter. The total revenue for the quarter stood at Rs. 5402.00 millions against Rs. 5145.30 millions during year ago period.Profit after Tax for the quarter ended December 2022 saw a decline of -41.57% from Rs. 452.00 millions to Rs. 264.10  millions.The Operating Profit of the company witnessed a decrease to 770.90 millions from 934.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 5402.00 5145.30 4.99 14777.40 14403.70 2.59 19427.20 17204.40 12.92
Other Income 25.10 5.70 340.35 70.30 46.20 52.16 48.90 49.80 -1.81
PBIDT 770.90 934.80 -17.53 1740.10 2841.40 -38.76 3454.50 3278.70 5.36
Interest 130.30 71.80 81.48 351.20 231.30 51.84 312.10 362.00 -13.78
PBDT 640.60 863.00 -25.77 1388.90 2610.10 -46.79 3142.40 2916.70 7.74
Depreciation 282.70 246.80 14.55 821.80 714.40 15.03 956.70 852.40 12.24
PBT 357.90 616.20 -41.92 567.10 1895.70 -70.08 2185.70 2064.30 5.88
TAX 93.80 164.20 -42.87 144.00 498.20 -71.10 580.60 732.80 -20.77
Deferred Tax -10.50 -5.20 101.92 -13.80 -20.30 -32.02 -15.90 -62.70 -74.64
PAT 264.10 452.00 -41.57 423.10 1397.50 -69.72 1605.10 1331.50 20.55
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 14.27 18.17 -21.45 11.78 19.73 -40.31 17.78 19.06 -6.69

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.